HIV-Related Patents

 

Tumor Cytotoxicity Induced by Modulators of the CXCR4 Receptor
[1] 12/25/2007, USP 7,312,305 B2
[2] 06/14/2011, USP 7,960,346
[3] 09/02/14, EP1620056

This invention relates to the use of HIV-1-, HIV-2-, SIV- or FIV- associated gp120 molecules as therapeutic agents against epithelial carcinomas.


Modulating Vaccine against HIV-1 Nef Protein Induced Lymphocyte Depletion 
[1] 5/17/2011, USP 7,943,139

This invention relates to the use of identified apoptotic motif sequences in HIV Nef as targets for a vaccine that would block Nef apoptotic motif driven pathogenesis. 


Method for Treating AIDS or Cancer by Inhibiting the Secretion of Microparticles
[1] 04/30/2013, USP 8,431,530

Continuation patents:
[2] 07/02/2013, USP 8,476,237;
[3] 10/08/2013, USP 8,551,943B2;
[4] 10/22/2013, USP 8,563,506B2;
[5] 10/28/2014, USP 8,871708B2;

European Patent: [6] 08/14/2013, #2440570;

Germany National Patent: [7] #60 2010 009 528.2

Relates to the medical treatment and, in particular, to a method for treating AIDS or cancer by inhibiting the secretion of microparticles


Antimicrobial Compositions and Methods of Use Thereof
Utility Patent: [1] 3/11/2014, USP8,669,266 B2

Relates to the medical treatment and, in particular, to antimicrobial compositions and method for treating microbial infections.